Reardon Andrew
CIK 0001950232 Name as filed on the most recent filing
Filed as Reardon Andrew (13)
56 transaction lines · from 13 filings · filed 2023-03-28 to 2026-08-04 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
56 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-03 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 1,214 disposed | 287.77 | 349,356.54 | Form 4, filing 0002001011-26-000111 | |
| 2026-08-03 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 1,032 disposed | 286.80 | 295,974.30 | Form 4, filing 0002001011-26-000111 | |
| 2026-08-03 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 991 disposed | 291.71 | 289,086.49 | Form 4, filing 0002001011-26-000111 | |
| 2026-08-03 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 503 disposed | 289.80 | 145,770.51 | Form 4, filing 0002001011-26-000111 | |
| 2026-08-03 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 409 disposed | 292.82 | 119,763.01 | Form 4, filing 0002001011-26-000111 | |
| 2026-08-03 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 356 disposed | 288.75 | 102,794.86 | Form 4, filing 0002001011-26-000111 | |
| 2026-08-03 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 200 disposed | 290.60 | 58,120.00 | Form 4, filing 0002001011-26-000111 | |
| 2026-08-03 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 157 disposed | 285.74 | 44,860.50 | Form 4, filing 0002001011-26-000111 | |
| 2026-08-03 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 105 disposed | 284.14 | 29,834.44 | Form 4, filing 0002001011-26-000111 | |
| 2026-08-03 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 33 disposed | 284.55 | 9,390.25 | Form 4, filing 0002001011-26-000111 | |
| 2026-07-01 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 1,119 disposed | 311.72 | 348,814.68 | Form 4, filing 0002001011-26-000108 | |
| 2026-07-01 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 1,081 disposed | 312.28 | 337,572.95 | Form 4, filing 0002001011-26-000108 | |
| 2026-07-01 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 900 disposed | 315.78 | 284,199.75 | Form 4, filing 0002001011-26-000108 | |
| 2026-07-01 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 700 disposed | 313.46 | 219,420.18 | Form 4, filing 0002001011-26-000108 | |
| 2026-07-01 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 600 disposed | 317.15 | 190,291.02 | Form 4, filing 0002001011-26-000108 | |
| 2026-07-01 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 396 disposed | 308.99 | 122,359.49 | Form 4, filing 0002001011-26-000108 | |
| 2026-07-01 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 104 disposed | 310.20 | 32,261.04 | Form 4, filing 0002001011-26-000108 | |
| 2026-07-01 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 100 disposed | 314.58 | 31,457.88 | Form 4, filing 0002001011-26-000108 | |
| 2026-06-01 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 1,432 disposed | 225.97 | 323,585.03 | Form 4, filing 0002001011-26-000083 | |
| 2026-06-01 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 1,216 disposed | 229.47 | 279,032.60 | Form 4, filing 0002001011-26-000083 | |
| 2026-06-01 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 677 disposed | 225.20 | 152,459.25 | Form 4, filing 0002001011-26-000083 | |
| 2026-06-01 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 584 disposed | 228.57 | 133,487.10 | Form 4, filing 0002001011-26-000083 | |
| 2026-06-01 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 491 disposed | 223.95 | 109,957.83 | Form 4, filing 0002001011-26-000083 | |
| 2026-06-01 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 400 disposed | 226.78 | 90,711.76 | Form 4, filing 0002001011-26-000083 | |
| 2026-06-01 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 200 disposed | 230.41 | 46,082.00 | Form 4, filing 0002001011-26-000083 | |
| 2026-05-01 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 1,420 disposed | 232.92 | 330,749.24 | Form 4, filing 0002001011-26-000046 | |
| 2026-05-01 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 932 disposed | 228.75 | 213,198.45 | Form 4, filing 0002001011-26-000046 | |
| 2026-05-01 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 800 disposed | 234.02 | 187,214.16 | Form 4, filing 0002001011-26-000046 | |
| 2026-05-01 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 780 disposed | 232.04 | 180,991.12 | Form 4, filing 0002001011-26-000046 | |
| 2026-05-01 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 600 disposed | 227.45 | 136,469.58 | Form 4, filing 0002001011-26-000046 | |
| 2026-05-01 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 370 disposed | 230.87 | 85,421.60 | Form 4, filing 0002001011-26-000046 | |
| 2026-05-01 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 98 disposed | 229.71 | 22,511.44 | Form 4, filing 0002001011-26-000046 | |
| 2026-04-01 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 1,302 disposed | 199.72 | 260,038.17 | Form 4, filing 0002001011-26-000037 | |
| 2026-04-01 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 1,238 disposed | 200.94 | 248,767.31 | Form 4, filing 0002001011-26-000037 | |
| 2026-04-01 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 963 disposed | 203.22 | 195,702.59 | Form 4, filing 0002001011-26-000037 | |
| 2026-04-01 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 700 disposed | 201.90 | 141,327.97 | Form 4, filing 0002001011-26-000037 | |
| 2026-04-01 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 460 disposed | 198.85 | 91,470.68 | Form 4, filing 0002001011-26-000037 | |
| 2026-04-01 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 337 disposed | 204.50 | 68,917.38 | Form 4, filing 0002001011-26-000037 | |
| 2026-03-04 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 1,446 disposed | 208.12 | 300,939.06 | Form 4, filing 0002001011-26-000024 | |
| 2026-03-04 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 1,142 disposed | 208.87 | 238,532.28 | Form 4, filing 0002001011-26-000024 | |
| 2026-03-04 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 612 disposed | 207.01 | 126,689.45 | Form 4, filing 0002001011-26-000024 | |
| 2026-03-04 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 460 disposed | 205.18 | 94,381.88 | Form 4, filing 0002001011-26-000024 | |
| 2026-03-04 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 340 disposed | 206.37 | 70,164.78 | Form 4, filing 0002001011-26-000024 | |
| 2026-03-04 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 300 disposed | 201.70 | 60,510.00 | Form 4, filing 0002001011-26-000024 | |
| 2026-03-04 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 207 disposed | 199.96 | 41,390.89 | Form 4, filing 0002001011-26-000024 | |
| 2026-03-04 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 200 disposed | 204.17 | 40,834.00 | Form 4, filing 0002001011-26-000024 | |
| 2026-03-04 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 100 disposed | 199.00 | 19,900.50 | Form 4, filing 0002001011-26-000024 | |
| 2026-03-04 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 100 disposed | 197.70 | 19,769.54 | Form 4, filing 0002001011-26-000024 | |
| 2026-03-04 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 93 disposed | 200.62 | 18,657.89 | Form 4, filing 0002001011-26-000024 | |
| 2025-06-23 |
Ligand Pharmaceuticals Inc LGND |
S, Open-market sale | 500 disposed | 114.08 | 57,042.15 | Form 4, filing 0002001011-25-000048 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 0
- Open-market sale 56
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Reardon Andrew, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001950232
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6